103 related articles for article (PubMed ID: 2232197)
21. The use of hematopoietic growth and differentiation factors for bone marrow stimulation.
Moore MA
Important Adv Oncol; 1988; ():31-54. PubMed ID: 3042609
[No Abstract] [Full Text] [Related]
22. Effect of recombinant human granulocyte-macrophage colony-stimulating factor on hematopoietic reconstitution after high-dose chemotherapy and autologous bone marrow transplantation.
Brandt SJ; Peters WP; Atwater SK; Kurtzberg J; Borowitz MJ; Jones RB; Shpall EJ; Bast RC; Gilbert CJ; Oette DH
N Engl J Med; 1988 Apr; 318(14):869-76. PubMed ID: 3281007
[TBL] [Abstract][Full Text] [Related]
23. Clinical promise of new hematopoietic growth factors: M-CSF, IL-3, IL-6.
Garnick MB; O'Reilly RJ
Hematol Oncol Clin North Am; 1989 Sep; 3(3):495-509. PubMed ID: 2698879
[TBL] [Abstract][Full Text] [Related]
24. Treatment of a marrow stem-cell disorder with granulocyte colony-stimulating factor.
Quesenberry PJ
N Engl J Med; 1989 May; 320(20):1343-5. PubMed ID: 2469957
[No Abstract] [Full Text] [Related]
25. CSFs, from basic science to clinical trials.
Aglietta M; Gavosto F
Bone Marrow Transplant; 1989 Jan; 4 Suppl 1():16-8. PubMed ID: 2653496
[No Abstract] [Full Text] [Related]
26. Aplastic anemia: research themes and clinical issues.
Young N
Prog Hematol; 1981; 12():227-73. PubMed ID: 7041174
[No Abstract] [Full Text] [Related]
27. Human recombinant derived IL-3 and GM-CSF in hematopoiesis of normal cynomolgus monkeys.
Krumwieh D; Weinmann E; Seiler FR
Behring Inst Mitt; 1988 Aug; (83):250-7. PubMed ID: 3071338
[TBL] [Abstract][Full Text] [Related]
28. Colony-stimulating factors and their relevance to long-term bone marrow cultures.
Shadduck RK; Waheed A
Kroc Found Ser; 1984; 18():339-54. PubMed ID: 6397575
[No Abstract] [Full Text] [Related]
29. Advances in hemopoietic stem cell research.
Miura Y
Nihon Ketsueki Gakkai Zasshi; 1987 Dec; 50(8):1491-8. PubMed ID: 3502305
[No Abstract] [Full Text] [Related]
30. Bone marrow failure and hematopoietic growth factors.
Douer D
Isr J Med Sci; 1989 Apr; 25(4):183-5. PubMed ID: 2468629
[No Abstract] [Full Text] [Related]
31. Opposite effect of tumor necrosis factor alpha on granulocyte colony-stimulating factor and granulocyte-macrophage colony-stimulating factor-dependent growth of normal and leukemic hemopoietic progenitors.
Piacibello W; Sanavio F; Severino A; Morelli S; Vaira AM; Stacchini A; Aglietta M
Cancer Res; 1990 Aug; 50(16):5065-71. PubMed ID: 1696165
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-3 followed by GM-CSF for delayed engraftment after autologous bone marrow transplantation.
Crump M; Couture F; Kovacs M; Saragosa R; McCrae J; Brandwein J; Huebsch L; Beauregard-Zollinger L; Keating A
Exp Hematol; 1993 Mar; 21(3):405-410. PubMed ID: 8440338
[TBL] [Abstract][Full Text] [Related]
33. The effect of human recombinant granulocyte-macrophage colony stimulating factor on the proliferation and differentiation of myeloid progenitors in congenital agranulocytosis marrow cells.
Hassan HT; Rees JK
Haematologia (Budap); 1989; 22(4):233-8. PubMed ID: 2696709
[TBL] [Abstract][Full Text] [Related]
34. Hematopoietic growth factors in bone marrow transplantation: current and future directions.
Aurer I; Ribas A; Gale RP
Haematologica; 1991; 76(2):85-8. PubMed ID: 1682224
[No Abstract] [Full Text] [Related]
35. Recombinant GM-CSF in patients with poor graft function after bone marrow transplantation.
Klingemann HG; Eaves AC; Barnett MJ; Reece DE; Shepherd JD; Belch AR; Brandwein JM; Langleben A; Koch PA; Phillips GL
Clin Invest Med; 1990 Apr; 13(2):77-81. PubMed ID: 2191816
[TBL] [Abstract][Full Text] [Related]
36. Enhanced reconstitution of hematopoietic organs in irradiated mice, following their transplantation with bone marrow cells pretreated with recombinant interleukin 3.
Fabian I; Bleiberg I; Riklis I; Kletter Y
Exp Hematol; 1987 Dec; 15(11):1140-4. PubMed ID: 3315725
[TBL] [Abstract][Full Text] [Related]
37. [Colony-stimulating factors. Therapeutic applications].
Kusminsky GD; Koziner B
Sangre (Barc); 1990 Oct; 35(5):381-7. PubMed ID: 2291148
[No Abstract] [Full Text] [Related]
38. Hematopoietic growth factors: biologic complexity and clinical promise.
Nienhuis AW
N Engl J Med; 1988 Apr; 318(14):916-8. PubMed ID: 3281008
[No Abstract] [Full Text] [Related]
39. The use of recombinant human granulocyte-macrophage colony stimulating factor for the treatment of delayed engraftment following high dose therapy and autologous hematopoietic stem cell transplantation for lymphoid malignancies.
Vose JM; Bierman PJ; Kessinger A; Coccia PF; Anderson J; Oldham FB; Epstein C; Armitage JO
Bone Marrow Transplant; 1991 Feb; 7(2):139-43. PubMed ID: 1675592
[TBL] [Abstract][Full Text] [Related]
40. Enrichment of CD34 (My10)-positive myeloid and erythroid progenitors from human marrow and their growth in cultures supplemented with recombinant human granulocyte-macrophage colony-stimulating factor.
Baines P; Mayani H; Bains M; Fisher J; Hoy T; Jacobs A
Exp Hematol; 1988 Oct; 16(9):785-9. PubMed ID: 2458955
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
